wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q58803309-1DD3EEFE-2D0F-4C91-B733-6B8537749933
Q58803309-1DD3EEFE-2D0F-4C91-B733-6B8537749933
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58803309-1DD3EEFE-2D0F-4C91-B733-6B8537749933
New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis
P2860
Q58803309-1DD3EEFE-2D0F-4C91-B733-6B8537749933
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58803309-1DD3EEFE-2D0F-4C91-B733-6B8537749933
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2ac3f46b5af36bd8f6b28ea1864b7305d08e0a76
P2860
First-in-human randomized study of bimekizumab, a humanized monoclonal antibody and selective dual inhibitor of IL-17A and IL-17F, in mild psoriasis